IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn.
The deal will be the biggest ever transaction in...
GERMAN cannabis firm Sanity kept a clear head to secure $4.8m of new investment - despite the European Commission’s recent narcotic CBD implosion.
Its latest...
CANNABIS stocks are expected to maintain their post-Election surge this week with Joe Biden now confirmed as the 46th President of the United States...
IN spite of its delayed arrival Europe has a first-class opportunity to become a world-leader in the emerging global cannabis industry.
This is one of...
THE local corner shop has never been so busy, with stock squeezed into every conceivable corner a former struggling business has been transformed and...
PRESS RELEASE
FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...